Elekta is a company deeply committed to ensuring that every patient has access to the best possible cancer care. Our customers, clinicians and healthcare providers worldwide, face the immense challenge of treating cancer and brain disorders with precision and efficacy. This is why, for nearly five decades, we have dedicated ourselves to pioneering advances in radiation therapy, radiosurgery, and related oncology software. We understand that to make a real difference, we need to work openly and proactively with those on the front lines of patient care. This collaborative approach allows us to develop sustainable, outcome-driven, and cost-efficient solutions that meet the continuously evolving needs of patients and the healthcare systems that support them.
Our global team of approximately 4,700 employees is driven by a personal commitment to this mission. We combine passion, science, and imagination to profoundly change cancer care. We don't just build technology; we build hope. From the Leksell Gamma Knife, a revolutionary tool for bloodless brain surgery, to advanced linear accelerators like the Versa HD and the groundbreaking Elekta Unity MR-Linac, our innovations are designed to enhance the delivery of precise and personalized treatments. We also provide comprehensive software solutions, such as the MOSAIQ oncology information system and Monaco treatment planning, to streamline workflows and improve clinical decision-making. Our focus extends beyond technology to include robust support services, education, and training, ensuring that our partners can maximize the potential of our solutions for the benefit of their patients. Ultimately, our goal is to improve lives and bring hope to everyone dealing with cancer, no matter where they are in the world.